Page 110 - Pharmacy Appeals 1/4/04 to 31/3/05

86 Remuneration and staff report

Table 15: Executive and non-executive director salaries and allowances1for 2021/22

Name and title Salary Expense Performance Long term All pension- Total
payments pay and performance related
(taxable) bonuses pay and bonuses benefits
£000 £000 £000 £000 £000
bands of total to bands of bands of bands of bands
£5,000 nearest £100 £5,000 £5,000 £2,500 of £5,000

Mike Pinkerton1 10-15 2,500 0 N/A N/A 10-15
2

(Interim Chair)

Martin Thomas3 50-55 2,700 0 N/A N/A 55-60
(Chair)

Helen Vernon 160-165 0 5-10 0 45-47.5 215-220
(Chief Executive)

Joanne Evans 120-125 1,500 0-5 0 35-37.5 160-165
(Director of Finance
and Corporate
Planning)

Dr Denise Chaffer 115-120 0 0 0 2.5-5 120-125
(Director of Safety
and Learning)

Vicky Voller 115-120 0 0 0 32.5-35 145-150
(Director of Advice
and Appeals)

Professor Keith 5-10 0 N/A N/A N/A 5-10
Edmonds4
(Non-executive
Member)
Charlotte Moar5 10-15 1,800 N/A N/A N/A 10-15
(Non-executive
Member)

1The executive and non-executive directors do not receive any non-cash benefits other than travel costs booked through the
corporate booking company for journeys to locations approved under NHS Resolution's travel and expenses policy. The gross
value of this benefit and any taxable expenses reimbursed are included in the Expense payments column of this table.
2 Mike Pinkerton commenced as NHS Resolution's Interim Chair on 29 January 2022. The interim chair full year equivalent
salary is in the band £60-65k. The non-executive director full year equivalent salary is in the band £5-1 Ok.
3 Martin Thomas' term of office ended on 28 January 2022. Martin Thomas' full year equivalent salary was in the band £60-65k.
4 Professor Keith Edmonds was reappointed as Non-executive Director until 30 September 2021, and then appointed as an associate non­
executive member from 1 October 2021 to 6 December 2021. Professor Keith Edmonds' full year equivalent salary was in the band £5-10k.

5 Charlotte Moar is also the Chair of the Audit and Risk Committee.